Abstract
Background
Endoscopic mucosal resection (EMR) has emerged for evaluation and treatment of esophageal nodules. We report our initial experience with EMR for T staging and management of early esophageal cancer.
Methods
We reviewed patients undergoing EMR for esophageal adenocarcinoma between 2008 and 2013. The primary outcome measure was needed for esophagectomy. Secondary outcomes included complete eradication of adenocarcinoma, recurrence or persistence of cancer, nodal status for those undergoing esophagectomy, and complications of endoscopic treatment.
Results
During the study period, 24 patients underwent EMR demonstrating carcinoma, and a grossly margin negative endoscopic resection was achieved in all cases. Ten patients (42 %) had evidence of submucosal invasion and were referred for esophagectomy. Patients with margin negative EMR (n = 10, 42 %) or positive radial margins (n = 4, 16 %) underwent endoscopic surveillance and treatment with radiofrequency ablation or repeat EMR as needed. Thirteen patients (93 %) with intramucosal cancer (IMC) have been successfully managed with ongoing endoscopic surveillance and treatment with a median follow-up of 15.5 months. One patient underwent esophagectomy due to recurrent IMC in the setting of long-segment multifocal high-grade dysplasia. There were no esophageal perforations, one patient developed a self-limited gastrointestinal hemorrhage following EMR, and one had an esophageal stricture following endoscopic management.
Conclusions
IMC can be successfully managed endoscopically and thus esophagectomy is avoided in a significant proportion of patients. Endoscopic management may be utilized in the setting of complete resection or radial margin involvement without evidence of submucosal invasion. Close endoscopic follow-up is of paramount importance even in those with negative margins, because recurrent disease may occur following EMR in these patients.
Similar content being viewed by others
References
Gopal DV, Jobe BA (2002) Screening for Barrett’s esophagus may not reduce morbidity and mortality due to esophageal adenocarcinoma— commentary. Evid Based Oncol 3:144–145
Spechler SJ (2002) Clinical practice: Barrett’s esophagus. N Engl J Med 346:836–842
Spechler SJ (2001) Screening and surveillance for complications related to gastroesophageal reflux disease. Am J Med 111:130S–136S
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96
Nealis TB, Washington K, Keswani RN (2011) Endoscopic therapy of esophageal premalignancy and early malignancy. J Natl Compr Canc Netw 9(8):890–899
Hvid-Jensen F, Pederson L, Drewes AM, Sørensen HT, Funch-Jensen P (2011) Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med 365:1375–1383
Crane SJ, Locke GR 3rd, Harmsen WS, Zinmeister AR, Romero Y, Taley NJ (2008) Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc 83(10):1087–1094
Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma—an American single-center experience. Am J Gastroenterol 104(11):2684–2692
Enestvedt BK, Ginsberg GG (2013) Advances in endoluminal therapy for esophageal cancer. Gastrointest Endosc Clin N Am 23(1):17–39
Perry KA, Walker JP, Salazar M, Suzo A, Hazey JW, Melvin WS (2013) Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center. Surg Endosc Published online
Luna RA, Gilbert E, Hunter JG (2012) High-grade dysplasia and intramucosal adenocarcinoma in Barrett’s esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Curr Opin Gastroenterol 28(4):362–369
Saligram S, Chennat J, Hu H, Davison JM, McGrath K, Fasanella K (2013) Endotherapy for superficial adenocarcinoma of the esophagus: an American experience. Gastrointest Endosc 77(6):872–876
Chadwick G, Groene O, Markar SR, Hoare J, Cromwell D, Hanna GB (2014) Systemic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett’s esophagus: a critical assessment of histologic outcomes and adverse events. Gastrointest Endosc 5107(13):6–02626
Anderegg MC, Gisbertz SS, van Berge Henegouwen MI (2014) Minimally invasive surgery for oesophageal cancer. Best Pract Res Clin Gastroenterol 28(1):41–52
Crumley AB, Going JJ, McEwan K, McKernan M, Abela JE, Shearer CJ, Stanley AJ, Stuart RC (2011) Endoscopic mucosal resection for gastroesophageal cancer in a U.K. population. Long-term follow-up of a consecutive series. Surg Endosc 25(2):543–548
Pouw RE, Wirths K, Eisendrath P, Sondermeijer CM, Ten Kate FJ, Fockens P, Devie`re J, Neuhaus H, Bergman JJ (2010) Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 8:23–29
Mino-Kenudson M, Brugge WR, Puricelli WP et al (2005) Management of superficial Barrett’s epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol 29(5):680–686
Goldminc M, Maddern G, Le Prise E, Meunier B, Campion JP, Launois B (1993) Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 80:367–370
Jacobi CA, Zieren HU, Muller JM, Pichlmaier H (1997) Surgical therapy of esophageal carcinoma: the influence of surgical approach and esophageal resection on cardiopulmonary function. Eur J Cardiothorac Surg 11:32–37
Isomoto H, Yamaguchi N, Minami H, Nakao K (2013) Management of complications associated with endoscopic submucosal dissection/endoscopic mucosal resection for esophageal cancer. Dig Endosc 25(Suppl 1):29–38
O’Farrell NJ, Reynolds JV, Ravi N, Larkin JO, Malik V, Wilson GF, Muldoon C, O’Toole D (2013) Evolving changes in the management of early oesophageal adenocarcinoma in a tertiary centre 182(3):363–369
Inoue H, Minami H, Kaga M, Kudo SE (2010) Endoscopic mucosal resection and endoscopic submucosal dissection for esophageal dysplasia and carcinoma. Gastrointest Endosc Clin N Am 20(1):25–34
Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R, Chang KJ, Muthasamy R, Lightdale CJ, Santi- ago N, Pleskow DK, Dean PJ, Wang KK (2010) Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 42:781–789
Acknowledgments
The authors would like to thank Rebecca Dettorre, MA, CCRC, Research Coordinator for the Center for Minimally Invasive Surgery, for her assistance with this project.
Disclosures
Drs. Huntington, Walker, Meara, Hazey, Melvin, and Perry report no biomedical financial interests or potential conflicts of interest relevant to the subject matter of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huntington, J.T., Walker, J.P., Meara, M.P. et al. Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience. Surg Endosc 29, 2121–2125 (2015). https://doi.org/10.1007/s00464-014-3962-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-014-3962-3